SCHEDULE 13G/A 0001580642-24-006950 0001442891 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value 12/31/2024 0000906709 Nektar Therapeutics 640268108 455 Mission Bay Boulevard South San Francisco CA 94158 Rule 13d-1(b) Eventide Asset Management, LLC DE 6650000.00 0.00 6650000.00 0.00 6650000.00 N 3.61 IA Finny Kuruvilla, M.D., Ph. D. X1 0.00 6650000.00 0.00 6650000.00 6650000.00 N 3.61 HC IN Robin C. John X1 0.00 6650000.00 0.00 6650000.00 6650000.00 N 3.61 HC IN Nektar Therapeutics 455 Mission Bay Boulevard South, San Francisco, California 94158 Eventide Asset Management, LLC Finny Kuruvilla, M.D., Ph.D. Robin C. John Eventide, Kuruvilla and John: One International Place, Suite 4210 Boston, Massachusetts 02110 Eventide: Delaware Kuruvilla: United States John: United States N IA HC Eventide: 6,650,000 Kuruvilla: 6,650,000 John: 6,650,000 Eventide: 3.61% Kuruvilla: 3.61% John: 3.61% Eventide: 6,650,000 Kuruvilla: 0 John: 0 Eventide: 0 Kuruvilla: 6,650,000 John: 6,650,000 Eventide: 6,650,000 Kuruvilla: 0 John: 0 Eventide: 0 Kuruvilla: 6,650,000 John: 6,650,000 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. In accordance with Rule 13d-4 of the Securities Exchange Act of 1934, each of the persons filing this statement expressly disclaim the beneficial ownership of the securities covered by this statement and the filing of this report shall not be construed as an admission by such persons that they are the beneficial owners of such securities. EX 1 Eventide Asset Management, LLC /s/ Peter J. Luiso 02/10/2025 Finny Kuruvilla, M.D., Ph. D. /s/ Finny Kuruvilla, M.D., Ph. D. 02/10/2025 Robin C. John /s/ Robin C. John 02/10/2025